HTG Molecular Diagnostics Insider Trades

HTGM

Track insider trading activity from HTG Molecular Diagnostics executives and directors. See which insiders are buying and selling HTGM stock.

Trades Last 12 Months

HTGM Price

All Insider Trades for HTG Molecular Diagnostics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Barat Stephen Senior VP Of Therapeutics
Holding Value $202 421 shares
Last Trade
Jun 08, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$710 888 shares
$0.80
$0.48
Lawson Byron Svp/chief Commercial Officer
Holding Value $2.9k 6,033 shares
Last Trade
Dec 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.48k 1,000 shares
$6.48
$0.48
Godlewski Laura Lee SVP Finance & Administration
Holding Value $2.35k 4,904 shares
Last Trade
Dec 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.48k 1,000 shares
$6.48
$0.48
Lubniewski John L President & CEO
Holding Value $6.78k 14,133 shares
Last Trade
Dec 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.48k 1,000 shares
$6.48
$0.48
Mcmeans Shaun D Svp, Finance & Admin. & CFO
Holding Value $5.07k 10,570 shares
Last Trade
Dec 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.48k 1,000 shares
$6.48
$0.48
Holding Value $1.92k 4,000 shares
Last Trade
Sep 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$41.3k 4,000 shares
$10.32
$0.48
Mccracken Lee R. Director
Holding Value $1.92k 4,000 shares
Last Trade
Sep 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$41.3k 4,000 shares
$10.32
$0.48
Holding Value $1.92k 4,000 shares
Last Trade
Sep 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$41.3k 4,000 shares
$10.32
$0.48
Hanham Ann Director
Holding Value $3.84k 8,000 shares
Last Trade
Sep 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$82.6k 8,000 shares
$10.32
$0.48
Hardison Don M Director
Holding Value $1.92k 4,000 shares
Last Trade
Sep 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$41.3k 4,000 shares
$10.32
$0.48
Holding Value $3.84k 8,000 shares
Last Trade
Aug 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$90.4k 8,000 shares
$11.30
$0.48
George Harry A. Director
Holding Value $1.92k 4,000 shares
Last Trade
Aug 18, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$300k 4,000 shares
$75.00
$0.48
Lafrance James T Director
Holding Value $1.92k 4,000 shares
Last Trade
Aug 18, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$300k 4,000 shares
$75.00
$0.48
Johnson Tim B Executive Chairman
Holding Value $8.03k 16,738 shares
Last Trade
Dec 31, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$6.27k 109 shares
$57.48
$0.48
Lytton Laurence W 10% owner
Holding Value $1.1M 2,297,173 shares
Last Trade
Feb 25, 2020 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$429M 4,110,000 shares
$104.33
$0.48
Mc Means Shaun D Svp, Finance & Admin. & CFO
Holding Value $114k 237,500 shares
Last Trade
Jan 23, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.2M 237,500 shares
$118.55
$0.48
Holding Value $4.8k 10,000 shares
Last Trade
Aug 14, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.87M 10,000 shares
$187.20
$0.48
Roche Patrick C. SVP Medical/scientific Affairs
Holding Value $20.8k 43,421 shares
Last Trade
Jun 08, 2018 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$538k 788 shares
$682.20
$0.48
Gordon Debra A Svp, Chief Legal Counsel
Holding Value $34.8k 72,552 shares
Last Trade
Jan 29, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.5M 29,719 shares
$691.20
$0.48
Qiagen Nv 10% owner
Holding Value $361k 753,012 shares
Last Trade
Oct 26, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$337M 753,012 shares
$448.20
$0.48

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up